Description

Diacerein is an anthraquinone derivative that inhibits interleukin-1?, known for its disease-modifying effects in cartilage and osteoarthritis research. Kunming Jida Pharmaceutical’s Jidaxin’an formulation includes 50?mg per capsule, 20 capsules per box. It carries China NMPA approval H20233671 and product code 86905589001014, with barcode 6900191243269.

?? For laboratory research use only. Not intended for human or veterinary applications.

Product Specifications

Mechanism & Research Applications

Diacerein inhibits IL?1? activity and upregulates cartilage matrix production, making it suitable for research into:

• Osteoarthritis and cartilage degradation models

• Anti-inflammatory assays in chondrocyte cultures

• Comparative studies with NSAIDs or DMARDs

• Cartilage regeneration and joint protection mechanisms

Side Effects (Observed in Research Models)

Common effects noted in experimental and clinical studies include:

• Diarrhea and soft stool (noted during early use)

• Abdominal discomfort, flatulence

• Occasional elevated liver enzymes or dark urine

• Rare rash or itching
  

Safety & Handling

• Use Restriction: Laboratory research only.

• PPE Required: Gloves, lab coat, safety glasses.

• Storage: 20–25?°C, sealed, in a dry, dark place.

• Disposal: Follow institutional chemical waste guidelines.

Core Keywords

diacerein capsules 50mg, Jidaxinan diacerein, H20233671 diacerein, osteoarthritis research compound, cartilage protective agent, lab-grade diacerein, Kunming Jida pharmaceutical diacerein, wholesale diacerein capsules

Research Use Disclaimer

This product is intended exclusively for laboratory research. Not approved for clinical, diagnostic, therapeutic, or veterinary use. Misuse may result in health or regulatory consequences. Always follow institutional biosafety protocols.